Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving AstraZeneca (AZN)GlobeNewsWire • 07/14/26
AstraZeneca Enters Exclusive License Deal For Lung Cancer Drug Zegfrovy For Up to $1.5 BillionWSJ • 07/14/26
AZN Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into AstraZeneca (AZN)Business Wire • 07/13/26
AstraZeneca Updates 2030 Sustainability Goals as AI and Emissions Cuts Take Center StageMarketBeat • 07/11/26
AstraZeneca's trial flop raises a bigger question: Is its pipeline premium becoming more vulnerable?CNBC • 07/11/26
AZN SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving AstraZenecaPRNewsWire • 07/10/26
AstraZeneca Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into AstraZeneca (AZN)PRNewsWire • 07/10/26
AstraZeneca And Ionis Pharma Rocked By Heart Disease Fail: Why You Shouldn't PanicSeeking Alpha • 07/09/26
AstraZeneca's Wainua failure hurts credibility more than valuation, Jefferies warnsProactive Investors • 07/09/26
Why AstraZeneca Crashed 8%, Leading Three Rivals, Including Pfizer, To JumpInvestors Business Daily • 07/09/26
AstraZeneca's £19bn blow as Wainua heart drug fails key late-stage trialProactive Investors • 07/09/26